Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by CEPHALON
FDA Drug Application 021875 by CEPHALON
Application Number
021875
Application Type
New Drug Application
Sponsor Applicant
CEPHALON
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New manufacturer
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
6/15/2007
N
16830
000
http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021875lbl.pdf
6/27/2007
AP
0
6/15/2007
N
16929
000
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021875s000ltr.pdf
7/5/2007
AP
0
6/15/2007
N
21959
000
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/021875_nuvigil_toc.cfm
3/5/2009
AP
0
6/15/2007
N
36608
000
http://www.fda.gov/downloads/Drugs/DrugSafety/UCM231717.pdf
7/26/2013
AP
0
10/21/2010
SLR
26738
005
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021875s005,s008,s015ltr.pdf
10/25/2010
AP
0
10/21/2010
SLR
26750
005
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021875s005s008s015lbl.pdf
10/25/2010
AP
0
10/21/2010
SLR
26753
005
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021875s005s008s015MedGuide.pdf
10/25/2010
AP
0
3/26/2009
SCF
22148
006
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021875s006ltr.pdf
4/1/2009
AP
0
10/21/2010
SLR
26739
008
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021875s005,s008,s015ltr.pdf
10/25/2010
AP
0
10/21/2010
SLR
26751
008
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021875s005s008s015lbl.pdf
10/25/2010
AP
0
10/21/2010
SLR
26754
008
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021875s005s008s015MedGuide.pdf
10/25/2010
AP
0
6/28/2013
SLR
36405
012
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021875Orig1s012ltr.pdf
7/2/2013
AP
0
6/28/2013
SLR
36560
012
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021875s012lbl.pdf
7/15/2013
AP
0
10/21/2010
SLR
26740
015
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/021875s005,s008,s015ltr.pdf
10/25/2010
AP
0
10/21/2010
SLR
26752
015
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021875s005s008s015lbl.pdf
10/25/2010
AP
0
10/21/2010
SLR
26755
015
http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021875s005s008s015MedGuide.pdf
10/25/2010
AP
0
1/13/2012
SLR
31410
016
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020717s040,s041,021875s016,s017ltr.pdf
1/19/2012
AP
0
1/13/2012
SLR
31411
017
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/020717s040,s041,021875s016,s017ltr.pdf
1/19/2012
AP
0
4/5/2013
SCM
AP
0
8/23/2013
SCM
AP
0
2/9/2015
SCM
AP
0
4/15/2015
SLR
42543
021
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021875s021lbledt.pdf
4/16/2015
AP
0
4/15/2015
SLR
42552
021
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021875Orig1s021ltr.pdf
4/17/2015
Back to FDA Applications sponsored by CEPHALON